Composition and methods for WTI specific immunotherapy
US7063854B1 · kind B1 · utility
40Cited by
9References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 30, 1998 |
| Grant date | Jun 20, 2006 |
| Priority date | — |
| Expiry date | Sep 30, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/572
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypeptide; or a T cell that specifically reacts with a WT1 polypeptide. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.